1 results match your criteria: "Lianyungang Second People's Hospital (The Oncology Hospital of Lianyungang)[Affiliation]"
Changes in serum uric acid, glutathione, and amyloid-β1-42 levels in Parkinson's disease patients and their association with disease progression and cognitive decline.
Curr Med Res Opin
December 2024
Department of Neurology, Lianyungang Second People's Hospital (The Oncology Hospital of Lianyungang), Lianyungang, Jiangsu, China.
Objective: This study aims to evaluate the diagnostic significance of serum uric acid (UA), glutathione (GSH), and amyloid-β1-42 (Aβ1-42) levels in relation to disease progression and cognitive impairment in patients with Parkinson's disease (PD).
Methods: A total of 209 PD patients with disease duration ranging from 4.0 to 6.